130 related articles for article (PubMed ID: 24279440)
21. Detection of Methylated SEPT9 in Korean Colorectal Cancer Patients: Comparison with Previous Studies.
Kim H; Lee JK; Hong YJ; Moon SM; Shin US; Kwon H; Shin K; Chang YH
Clin Lab; 2018 Sep; 64(9):1573-1579. PubMed ID: 30273999
[TBL] [Abstract][Full Text] [Related]
22. Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test.
Chen Y; Wang Z; Zhao G; Sun C; Ma Y; Zhang L; Zheng M; Li H
Dis Markers; 2019; 2019():5232780. PubMed ID: 31089394
[TBL] [Abstract][Full Text] [Related]
23. Early detection of colorectal cancer: from conventional methods to novel biomarkers.
Vatandoost N; Ghanbari J; Mojaver M; Avan A; Ghayour-Mobarhan M; Nedaeinia R; Salehi R
J Cancer Res Clin Oncol; 2016 Feb; 142(2):341-51. PubMed ID: 25687380
[TBL] [Abstract][Full Text] [Related]
24. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B
PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039
[TBL] [Abstract][Full Text] [Related]
25. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
[TBL] [Abstract][Full Text] [Related]
26. The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location.
Song L; Jia J; Yu H; Peng X; Xiao W; Gong Y; Zhou G; Han X; Li Y
J Cancer Res Clin Oncol; 2017 Jun; 143(6):1093-1101. PubMed ID: 28224298
[TBL] [Abstract][Full Text] [Related]
27. [Expression and clinical significance of plasma methylated SEPT 9 gene in patients with primary liver cancer].
He N; Feng G; Zhang FN; Hao S; Li R; Zhao ZQ; Tian YW; Yan HL
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):265-270. PubMed ID: 37137852
[No Abstract] [Full Text] [Related]
28. Methylated Septin9 (m
Loomans-Kropp HA; Song Y; Gala M; Parikh AR; Van Seventer EE; Alvarez R; Hitchins MP; Shoemaker RH; Umar A
Cancer Res Commun; 2022 Feb; 2(2):90-98. PubMed ID: 35992328
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Different Blood Collection Tubes and Blood Storage Conditions for the Preservation and Stability of Cell-Free Circulating DNA for the Analysis of the Methylated
Distler J; Tetzner R; Weiss G; König T; Schlegel A; Bagrowski M
Adv Exp Med Biol; 2016; 924():175-178. PubMed ID: 27753040
[TBL] [Abstract][Full Text] [Related]
30. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer.
deVos T; Tetzner R; Model F; Weiss G; Schuster M; Distler J; Steiger KV; Grützmann R; Pilarsky C; Habermann JK; Fleshner PR; Oubre BM; Day R; Sledziewski AZ; Lofton-Day C
Clin Chem; 2009 Jul; 55(7):1337-46. PubMed ID: 19406918
[TBL] [Abstract][Full Text] [Related]
31. Distinct Performance of Methylated
Tang H; Ma X; Zhou L; Li W; Shu Y; Xu H; Li J; Wang F; Sun F; Duan Y
Genet Test Mol Biomarkers; 2022 Apr; 26(4):239-248. PubMed ID: 35481971
[No Abstract] [Full Text] [Related]
32. Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening Setting.
Werner S; Krause F; Rolny V; Strobl M; Morgenstern D; Datz C; Chen H; Brenner H
Clin Cancer Res; 2016 Apr; 22(7):1725-33. PubMed ID: 26561557
[TBL] [Abstract][Full Text] [Related]
33. Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study.
Kubisch CH; Crispin A; Mansmann U; Göke B; Kolligs FT
Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1612-1618.e3. PubMed ID: 27085763
[TBL] [Abstract][Full Text] [Related]
34. Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening.
Wu D; Zhou G; Jin P; Zhu J; Li S; Wu Q; Wang G; Sheng J; Wang J; Song L; Han X; Qian J
J Mol Diagn; 2016 Jul; 18(4):535-45. PubMed ID: 27133379
[TBL] [Abstract][Full Text] [Related]
35. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
[TBL] [Abstract][Full Text] [Related]
36. A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis.
Song L; Yu H; Jia J; Li Y
Cancer Biomark; 2017; 18(4):425-432. PubMed ID: 28128742
[TBL] [Abstract][Full Text] [Related]
37. Detection of methylated septin 9 DNA in blood for diagnosis, prognosis, and surveillance of colorectal cancer.
Leung WK; Shin VY; Law WL
Hong Kong Med J; 2019 Dec; 25 Suppl 9(6):32-34. PubMed ID: 31889033
[No Abstract] [Full Text] [Related]
38. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma.
Potter NT; Hurban P; White MN; Whitlock KD; Lofton-Day CE; Tetzner R; Koenig T; Quigley NB; Weiss G
Clin Chem; 2014 Sep; 60(9):1183-91. PubMed ID: 24938752
[TBL] [Abstract][Full Text] [Related]
39. Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future.
Li Y; Song L; Gong Y; He B
Biomark Med; 2014; 8(5):755-69. PubMed ID: 25123042
[TBL] [Abstract][Full Text] [Related]
40. mSEPT9 (Epi proColon) Blood Test for Colorectal Cancer Screening.
Lin KW
Am Fam Physician; 2019 Jul; 100(1):10-11. PubMed ID: 31259500
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
